GA-map® Dysbiosis Test Lx
Innovative gut microbiota test to identify dysbiosis from faecal samples. The test employs 48 highly specific probes targeting predetermined multiplex targets and single nucleotide differences in the 16S rRNA gene of bacteria. The cutting-edge, high throughput technology detects over 300 bacterial species across taxonomic levels in a single reaction, providing efficient and accurate microbiota characterisation.
Receive your quote directly from the manufacturer.
The GA-map® Dysbiosis Test Lx is a cutting-edge clinical tool designed to identify and characterise dysbiosis, an imbalance in the gut microbiota associated with various health conditions like IBS, IBD and lifestyle diseases. By generating detailed gut microbiota profiles, it provides actionable insights to support patient treatment and clinical research. The test analyses faecal specimens and uses advanced bioinformatics to deliver accurate and reproducible results, helping clinicians and researchers understand the role of the microbiota in health and disease.
This CE-marked, ISO-certified test employs 48 highly specific probes targeting bacterial 16S rRNA gene sequences, enabling the identification of over 300 bacterial species in a single reaction. The test is fully validated, and can be set up in any PCR laboratory or processed at the GA-map service laboratory in Oslo, Norway, offering flexibility and convenience for users. Results are presented in an easy-to-interpret format, including a customised dysbiosis index and bacteria abundance data, compared against a healthy reference population.
With its standardisation, clinical validation and seamless integration into diagnostic workflows, the GA-map Dysbiosis Test Lx stands out as a reliable and efficient tool for understanding and managing gut microbiota-related conditions.
Key features and benefits:
- High specificity – identifies over 300 bacterial species using 48 specific probes targeting 16S rRNA genes
- Reproducible and standardised – validated through clinical studies and ISO-certified processes, ensuring consistent results
- Flexible testing options – available for use in PCR labs or via the service laboratory
- Easy results interpretation – with case-specific profiles and dysbiosis index as well as abundance data tailored to specific research or clinical needs, enabling precise microbiota profiling
- Backed by extensive research – CE-marked, ISO-certified and clinically validated
Relevant applications:
- Clinical treatment support for conditions like IBS, IBD, type 2 diabetes and leaky gut syndrome
- Research on gut microbiota's role in health, lifestyle diseases and gastrointestinal disorders
- Bioinformatic analysis of microbiota profiles in population studies
